Shots: Coherus announces the Federal Circuit affirmation decision of the US District Court for the District of Delaware appealing that Coherus’ Udenyca (biosimilar, pegfilgrastim) does not infringe Amgen’s asserted patent […]readmore
Tags : Patent
Shots: Pfizer to get worldwide IPR for Humira in the US and other countries and will pay royalties on sales to AbbVie Humira’s the US license right will begin from […]readmore